Laddar...
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors
CTLA-4 is an immune checkpoint expressed on active anticancer T cells. When it combines with its ligand B7 on dendritic cells, it inhibits the activity of the T cells. The Bromo- and Extra-Terminal (BET) protein family includes proteins that regulate the expression of key oncogenes and antiapoptotic...
Sparad:
| I publikationen: | Proc Natl Acad Sci U S A |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
National Academy of Sciences
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003484/ https://ncbi.nlm.nih.gov/pubmed/29735668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1721559115 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|